USPTO serial 76314395
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William H. Brewster
WILLIAM H BREWSTER KILPATRICK & STOCKTON1100 PEACHTREE ST NE STE 2800ATLANTA, GA 30309-4530UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Delipidated biological fluids for human or animal use; delipidated blood substitutes for human or animal use; delipidated plasma substitutes for human or animal use; delipidated blood or plasma substitutes that reduce levels of infectious agents for human or animal use; delipidated blood or plasma substitutes that have reduced levels of lipid-containing organisms for human or animal use; delipidated blood or plasma substitutes that reduce levels of lipid-soluble substances for human or animal use | ACTIVE | — |
| 010 | Medical devices, namely, devices for removing and treating fluids for the purpose of removing lipids, lipid-containing organisms or lipid-soluble substances; devices for removing blood, separating cells from plasma, and treating plasma for the purpose of removing lipids; blood drawing devices; devices for removing blood, separating cells from plasma and treating the plasma for the purpose of removing lipids and returning the delipidated plasma to an animal or human; devices for treating fluids for the purpose of removing lipids; devices for treating plasma for the purpose of removing lipids; devices for treating plasma for the purpose of damaging or removing lipid-containing infectious agents in the plasma | ACTIVE | — |
| 042 | Medical services, namely, the removal of lipids from fluids; the damage or removal of lipid-containing organisms from fluids; the removal of lipid-soluble substances from fluids; the damage or removal of lipid-containing infectious agents from fluids; the removal of lipids from blood and blood fractions; the removal of lipids from plasma; the damage and removal of lipid-containing infectious agents from blood and blood fractions | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2003 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 3, 2002 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 10, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 25, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 23, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 23, 2002 | PAPER RECEIVED | — | |
| Nov 29, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 20, 2001 | DOCK | ASSIGNED TO EXAMINER | — |